BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29905389)

  • 1. Mortality in bullous pemphigoid: A systematic review and meta-analysis of standardized mortality ratios.
    Kridin K; Schwartz N; Cohen AD; Zelber-Sagi S
    J Dermatol; 2018 Sep; 45(9):1094-1100. PubMed ID: 29905389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed Individual-Aggregate Data on All-Cause Mortality in Bullous Pemphigoid: A Meta-analysis.
    Tedbirt B; Gillibert A; Andrieu E; Hébert V; Bastos S; Korman NJ; Tang MBY; Li J; Borradori L; Cortés B; Kim SC; Gual A; Xiao T; Wieland CN; Fairley JA; Ezzedine K; Joly P
    JAMA Dermatol; 2021 Apr; 157(4):421-430. PubMed ID: 33729430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality in Patients with Bullous Pemphigoid: A Retrospective Cohort Study, Systematic Review and Meta-analysis.
    Kridin K; Shihade W; Bergman R
    Acta Derm Venereol; 2019 Jan; 99(1):72-77. PubMed ID: 29963683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality in bullous pemphigoid and prognostic factors in 1st and 3rd year of follow-up in specialized centre in Poland.
    Kalinska-Bienias A; Lukowska-Smorawska K; Jagielski P; Kowalewski C; Wozniak K
    Arch Dermatol Res; 2017 Nov; 309(9):709-719. PubMed ID: 28852833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Death in Bullous Pemphigoid: A Retrospective Database Study in Finland.
    Försti AK; Jokelainen J; Timonen M; Tasanen K
    Acta Derm Venereol; 2016 Aug; 96(6):758-61. PubMed ID: 26806363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality of patients with bullous pemphigoid in Korea.
    Lee JH; Kim SC
    J Am Acad Dermatol; 2014 Oct; 71(4):676-83. PubMed ID: 24930586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.
    Liu YD; Wang YH; Ye YC; Zhao WL; Li L
    Arch Dermatol Res; 2017 Jul; 309(5):335-347. PubMed ID: 28317060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
    Ungprasert P; Wijarnpreecha K; Thongprayoon C
    Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios.
    Manouchehrinia A; Tanasescu R; Tench CR; Constantinescu CS
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):324-31. PubMed ID: 25935887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for mortality in bullous pemphigoid: A systematic review and meta-analysis.
    Chen X; Zhang Y; Luo Z; Wu Y; Niu T; Zheng J; Xie Y
    PLoS One; 2022; 17(4):e0264705. PubMed ID: 35427358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and mortality of bullous pemphigoid in France.
    Joly P; Baricault S; Sparsa A; Bernard P; Bédane C; Duvert-Lehembre S; Courville P; Bravard P; Rémond B; Doffoel-Hantz V; Bénichou J
    J Invest Dermatol; 2012 Aug; 132(8):1998-2004. PubMed ID: 22418872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality from acquired bullous diseases of skin in Canadian adults 2000-2007.
    Baibergenova AT; Weinstock MA; Shear NH
    Int J Dermatol; 2012 Nov; 51(11):1325-8. PubMed ID: 23067080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality and risk factors among Israeli bullous pemphigoid patients.
    Rozenblat M; Halaj A; Rozenblat T; Fisher S; Sah M; Dodiuk-Gad RP; Ziv M
    Arch Dermatol Res; 2019 Jan; 311(1):19-27. PubMed ID: 30382340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis.
    Atzmony L; Mimouni I; Reiter O; Leshem YA; Taha O; Gdalevich M; Hodak E; Mimouni D
    J Am Acad Dermatol; 2017 Oct; 77(4):691-699. PubMed ID: 28645646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between bullous pemphigoid and neurological disorders: a systematic review.
    Milani-Nejad N; Zhang M; Kaffenberger J
    Eur J Dermatol; 2017 Oct; 27(5):472-481. PubMed ID: 28681724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid.
    Kibsgaard L; Rasmussen M; Lamberg A; Deleuran M; Olesen AB; Vestergaard C
    Br J Dermatol; 2017 Jun; 176(6):1486-1491. PubMed ID: 28235244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality of bullous pemphigoid in the first year after diagnosis: a retrospective study in a Spanish medical centre.
    Gual A; Mascaró JM; Rojas-Farreras S; Guilabert A; Julià M; Iranzo P
    J Eur Acad Dermatol Venereol; 2014 Apr; 28(4):500-6. PubMed ID: 23279207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
    Jiirasutat N; Pongchareon P; Weschawalit S
    Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States.
    Parker SR; Dyson S; Brisman S; Pennie M; Swerlick RA; Khan R; Manos S; Korman BD; Xia Z; Korman NJ
    J Am Acad Dermatol; 2008 Oct; 59(4):582-8. PubMed ID: 18707800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis.
    Smyrke N; Dunn N; Murley C; Mason D
    Acta Neurol Scand; 2022 Mar; 145(3):360-370. PubMed ID: 34820847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.